Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours
暂无分享，去创建一个
C. Harbron | D. Hodgson | A. Lau | M. O’Connor | C. Womack | S. Dearden | C. Marsden | N. Gray | Sonia Eckersley | A. Kvist | R. Milner | J. Warwicker | Glen Hughes | Helen Wombwell | Donna Barnes | E. V. Dorp | B. Wellings